CClinicalTrials.gg
CompletedNCT01545466Updated Mar 12, 2013

Non-drug Interventions for Migraines

An interventional study of Mindfulness Based Stress Reduction (MBSR) in Migraine and Headache, sponsored by Brigham and Women's Hospital. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-03-12.

Sponsored by Brigham and Women's Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
19
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This proposal describes a randomized controlled pilot trial investigating feasibility, safety, and migraine frequency in patients with migraines who undergo an 8 week mindfulness based stress reduction (MBSR) program compared to a wait-list control group.

Read the detailed description

Preliminary research has shown MBSR to be effective in chronic pain syndromes and other mind/body interventions have shown good promise in the treatment of headaches. A randomized controlled trial (RCT) of yoga in migraine without aura patients by John and colleagues showed that yoga resulted in a significant decrease in headache frequency, pain index, and symptomatic medication usage compared to a self-care group. This RCT demonstrated that patients with headaches may benefit from a mind-body intervention. However, their yoga protocol was not specified, and participants were instructed to practice the technique only during the prodromal phase of a headache (prior to the pain becoming severe), so as an abortive intervention at the time of a headache. Thus, the investigators of this trial are proposing to evaluate the effect of MBSR on adults with migraines compared to an education control group. This study will add to the John study because, unlike many other mind-body interventions, MBSR offers the distinct advantage of a standardized protocol that has been used both clinically and in numerous research studies across a wide variety of conditions. Furthermore, MBSR teaches participants a daily practice that, if effective, could serve as a prophylactic intervention.

02

Conditions studied

  • Migraine
  • Headache

Keywords

  • Migraines
  • Behavioral
  • Complementary and Alternative Medicine
  • Mindfulness Meditation
  • Mindfulness Based Stress Reduction
03

In context

Migraine Disorders

1,528 studies on the registry are indexed under Migraine Disorders; 299 are open to participants now.

This study's enrollment of 19 is below the median of 80 across 1,175 interventional studies indexed under Migraine Disorders.

Browse Migraine Disorders studies →

Lead sponsor

Brigham and Women's Hospital is the lead sponsor of 1,236 studies on the registry; 224 are open to participants now.

Of its 116 completed or terminated interventional studies of FDA-regulated products, 64 (55%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Diagnosis of migraine (International Classification of Headache Disorders-II);21
  • 4-14 days with migraines/month
  • ≥one year of migraines
  • ≥18 years
  • Able and willing to attend weekly sessions and willing to participate in daily mindfulness assignments, up to 30-45 min/day
  • Agreeable to participate and to be randomized to either group
  • Fluent in English (since the treatment groups will be run in English)
  • Good general health with no additional diseases expected to interfere with the study

Exclusion criteria

Exclusion Criteria:

  • Current regular meditation/yoga practice
  • Any major systemic illness or unstable medical or psychiatric condition (e.g. suicide risk) requiring immediate treatment or that could lead to difficulty complying with the protocol
  • Diagnosis of medication overuse headache (International Classification of Headache Disorders-II);19
  • Current or planned pregnancy or breastfeeding
  • New prophylactic migraine medicine started within 4 weeks of the screening visit
  • Unwilling to maintain stable current doses of migraine medicines for the duration of trial
  • Failure to complete baseline diary recordings of migraine activity and medication use
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
19 participants (actual)

Study arms

  • Experimental
    Mindfulness Based Stress Reduction

    Participants will complete an 8 week course in Mindfulness Based Stress Reduction (MBSR), meeting once/week for 8 weeks and having a 4-6 hour retreat after the 6th class

    Behavioral: Mindfulness Based Stress Reduction (MBSR)

  • No intervention
    Wait-List Control Group

    These participants will continue in usual care during the trial and will be offered the intervention of MBSR after the trial is over.

Interventions

  • BehavioralMindfulness Based Stress Reduction (MBSR)

    MBSR involves 8 weekly 2 hour classes and one 4-6 hour retreat after the 6th class

06

What researchers measure

Primary outcomes

  1. Change in Migraine frequency from Baseline

    Change in the number of migraines per month from baseline(tracked with headache logs)

    Time frame: baseline, immediately post-intervention, 4 weeks post-intervention

Secondary outcomes

  1. Change in self-efficacy from baseline

    Change in self-efficacy from baseline(Headache Management Self-Efficacy Scale)

    Time frame: baseline, immediately post-intervention, 4 weeks post-intervention

  2. Change in perceived stress from baseline

    Change in Perceived stress scale from baseline

    Time frame: baseline, immediately post-intervention, 4 weeks post-intervention

  3. Change in migraine-related disability/impact from baseline

    Change in migraine-related disability/impact from baseline(one month MIDAS and HIT-6)

    Time frame: baseline, immediately post-intervention, 4 weeks post-intervention

  4. Change in anxiety from baseline

    Change in anxiety from baseline (state-trait anxiety measure)

    Time frame: baseline, immediately post-intervention, 4 weeks post-intervention

  5. Change in depression from baseline

    Change in depression from baseline(PHQ-9)

    Time frame: baseline, immediately post-intervention, 4 weeks post-intervention

  6. Change in mindfulness from baseline

    Change in mindfulness from baseline(Five facet mindfulness scale)

    Time frame: baseline, immediately post-intervention, 4 weeks post-intervention

  7. Qualitative interviews

    Participants will be interviewed qualitatively

    Time frame: immediately post-intervention

  8. Change in migraine severity from baseline

    Change in Migraine intensity (1-10) tracked via headache logs from baseline

    Time frame: baseline, immediately post-intervention, 4 weeks post-intervention

  9. Change in Migraine duration from baseline

    Length of migraines (tracked via headache logs)

    Time frame: baseline, immediately post-intervention, 4 weeks post-intervention

  10. Change in quality of life from baseline

    Change in Migraine specific quality of life from baseline

    Time frame: baseline, immediately post-intervention, 4 weeks post-intervention

07

Study locations

1 site
  • Brigham and Women's Hospital
    Boston, Massachusetts 02115, United States
08

References and documents

Publications

  • Wells RE, Burch R, Paulsen RH, Wayne PM, Houle TT, Loder E. Meditation for migraines: a pilot randomized controlled trial. Headache. 2014 Oct;54(9):1484-95. doi: 10.1111/head.12420. Epub 2014 Jul 18. PubMed 25041058 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 12, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01545466
Lead sponsor
Brigham and Women's Hospital
Responsible party
Rebecca Wells (Instructor, Brigham and Women's Hospital) — Principal investigator
First posted
Mar 6, 2012
Start date
Feb 2012
Primary completion
Oct 2012
Completion
Oct 2012
Last update
Mar 12, 2013

Study contacts

Rebecca E Wells, MD, MPH
study director · Brigham and Women's Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion